Synthesis and antitumor activity of 1,8-diaminoanthraquinone derivatives

被引:23
|
作者
Huang, HS
Chiu, HF
Lu, WC
Yuan, CL
机构
[1] Natl Def Med Ctr, Sch Pharm, Taipei 11490, Taiwan
[2] Cheng Hsin Med Ctr, Taipei, Taiwan
[3] Kaohsiung Med Univ, Dept Pharmacol, Kaohsiung, Taiwan
关键词
aminoanthraquinone; anthraquinone; cytotoxicity; rat glioma C6 cell; human hepatoma G2 cell; 2.2.15; cell;
D O I
10.1248/cpb.53.1136
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Continuing our ongoing studies on cytotoxic substances, a series of regioisomeric disubstituted aminoanthraquinone (DAAQ) derivatives have been synthesized as cytotoxic activity based on a proposed bioactive amino conformation. To assess the biological activity of amino-substitution in the side-chains of anthraquinone located at positions 1 and 8 of the anthraquinone ring system. The aim of the study was to determine if members of the anthraquinone family could be used as adjuncts to increase the growth inhibiting effect of anticancer agents in rat glioma C6 cells, human hepatoma G2 cells and 2.2.15 cells. In vitro cytotoxicity data is reported for the compounds and some indications of structure-activity relationships have been discerned. A number of compounds were found to have good cytotoxicity against proliferation in these three cell lines. This has led to the discovery some of the DAAQ as a conformationally constrained structure possessing anticancer properties that displays cytotoxicity for these above cell lines and is being investigated further.
引用
收藏
页码:1136 / 1139
页数:4
相关论文
共 50 条
  • [11] Synthesis and Antitumor Activity of Hederagenin Derivatives
    Huang Xing
    Zhang Changhao
    Deng Hao
    Shen Qingkun
    Guo Hongyan
    Quan Zheshan
    Li Zhiyong
    Jin Lili
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2022, 42 (09) : 2877 - 2887
  • [12] Synthesis and antitumor activity of capecitabine derivatives
    Xuedong Jia
    Xiujun Liu
    Jian Wang
    Minghua Wang
    Huiyuan Guo
    Mingliang Liu
    Chemical Research in Chinese Universities, 2015, 31 : 78 - 83
  • [13] Synthesis and Antitumor Activity of Indolemalylimide Derivatives
    Xu, Guiqing
    Hu, Yongzhou
    Zhang, Chong
    He, Qiaojun
    Yang, Bo
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2009, 29 (06) : 916 - 923
  • [14] Synthesis and Antitumor Activity of Staurosporine Derivatives
    Li, Gang
    Wu, Dan
    Xu, Yanchao
    He, Wenwen
    Wang, Dongyang
    Zhu, Weiming
    Wang, Liping
    NATURAL PRODUCT COMMUNICATIONS, 2022, 17 (06)
  • [15] Synthesis and Antitumor Activity of Scopoletin Derivatives
    Zhou, Jinpei
    Wang, Lei
    Wei, Lijuan
    Zheng, Yu
    Zhang, Huibin
    Wang, Yubin
    Cao, Peng
    Niu, Ao
    Wang, Jing
    Dai, Yue
    LETTERS IN DRUG DESIGN & DISCOVERY, 2012, 9 (04) : 397 - 401
  • [16] SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF SOME QUINOLINE AND 1,8-NAPHTHYRIDINE DERIVATIVES
    CHATTOPADHYAY, J
    BASU, SK
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 1990, 29 (01): : 98 - 100
  • [17] Synthesis and antibacterial activity of highly oxygenated 1,8-cineole derivatives
    Villecco, Margarita B.
    Catalan, Julieta V.
    Vega, Marta I.
    Garibotto, Francisco M.
    Enriz, Ricardo D.
    Catalan, Cesar A. N.
    NATURAL PRODUCT COMMUNICATIONS, 2008, 3 (03) : 303 - 312
  • [18] Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA
    Liang, Gui-Bin
    Wei, Jian-Hua
    Jiang, Hong
    Huang, Ri-Zhen
    Qin, Jing-Ting
    Wang, Hui-Ling
    Wang, Heng-Shan
    Zhang, Ye
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 210
  • [19] Novel benzofuran derivatives: synthesis and antitumor activity
    Othman, Dina I.
    Abdelal, Ali M. M.
    El-Sayed, Magda A.
    El Bialy, Serry A. A.
    HETEROCYCLIC COMMUNICATIONS, 2013, 19 (01) : 29 - 35
  • [20] Synthesis and Antitumor Activity of Novel Terephthalamide Derivatives
    Gu, Yifei
    Wu, Caiju
    Wang, Siqi
    Zhang, Shilin
    Lu, Yuan
    Si, Xinxin
    Jiang, Bailing
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2024, 44 (11) : 3497 - 3504